Capillary-free vascularized retina in patients with aggressive posterior retinopathy of prematurity and late retinal capillary formation
- PMID: 23542906
- PMCID: PMC3596613
- DOI: 10.3341/kjo.2013.27.2.109
Capillary-free vascularized retina in patients with aggressive posterior retinopathy of prematurity and late retinal capillary formation
Abstract
Purpose: To report the clinical features, clinical course, and treatment outcomes after laser photocoagulation in infants with aggressive posterior retinopathy of prematurity (APROP) and capillary-free zones in vascularized retina.
Methods: Six patients (12 eyes) with APROP and capillary-free zones in vascularized retina were retrospectively reviewed. Twelve eyes of six infants were included and were treated with laser photocoagulation for avascular retina and for capillary-free zones in vascularized retina, except for the posterior pole, and fundus findings were photographically-documented in sequence. In addition, anatomic and visual outcomes were evaluated with complications of APROP.
Results: Among all of the consecutive infants with APROP, capillary-free zones in vascularized retina were demonstrated in 24% of the infants. All of the infants were >27 weeks of gestation age and had birth weights >1,000 g. After laser treatment, 7 eyes (58.3%) had favorable outcomes, and late capillary filling in capillary-free zones of vascularized retina were noted, however 4 eyes (33.3%) progressed to retinal detachment and 1 eye (8.3%) was complicated by a retinal fold-distorting posterior pole. The visual outcomes were associated with anatomic outcomes.
Conclusions: The anatomic outcomes in infants with APROP who had capillary-free zones were comparable to previously reported infants with APROP. The late capillary filling of capillary-free zones in vascularized retina was noted, and angiogenesis was considered to be involved. This process toward normal capillary formation or neovascularization in APROP, might determine its outcome.
Keywords: Aggressive posterior retinopathy of prematurity; Angiogenesis; Capillaries.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures



Similar articles
-
Aggressive posterior retinopathy of prematurity: a review on current understanding.Eye (Lond). 2021 Apr;35(4):1140-1158. doi: 10.1038/s41433-021-01392-6. Epub 2021 Jan 29. Eye (Lond). 2021. PMID: 33514899 Free PMC article. Review.
-
Laser photocoagulation (810 nm diode) for threshold retinopathy of prematurity: a prospective randomized pilot study of treatment to ridge and avascular retina versus avascular retina alone.Int Ophthalmol. 2011 Feb;31(1):3-8. doi: 10.1007/s10792-010-9411-y. Epub 2010 Dec 31. Int Ophthalmol. 2011. PMID: 21194006 Clinical Trial.
-
Outcomes and prognostic factors for aggressive posterior retinopathy of prematurity following initial treatment with intravitreal ranibizumab.BMC Ophthalmol. 2018 Jun 26;18(1):150. doi: 10.1186/s12886-018-0815-1. BMC Ophthalmol. 2018. PMID: 29940900 Free PMC article.
-
Diode laser photocoagulation to the ridge and avascular retina in threshold retinopathy of prematurity.Retina. 2002 Feb;22(1):48-52. doi: 10.1097/00006982-200202000-00009. Retina. 2002. PMID: 11884878
-
Adult retinopathy of prematurity: treatment implications, long term sequelae, and management.Curr Opin Ophthalmol. 2021 Sep 1;32(5):489-493. doi: 10.1097/ICU.0000000000000787. Curr Opin Ophthalmol. 2021. PMID: 34231528 Review.
Cited by
-
Aggressive posterior retinopathy of prematurity: a review on current understanding.Eye (Lond). 2021 Apr;35(4):1140-1158. doi: 10.1038/s41433-021-01392-6. Epub 2021 Jan 29. Eye (Lond). 2021. PMID: 33514899 Free PMC article. Review.
-
Aggressive Posterior Retinopathy of Prematurity in a Premature Male Infant.Case Rep Ophthalmol. 2017 Jul 25;8(2):396-400. doi: 10.1159/000478694. eCollection 2017 May-Aug. Case Rep Ophthalmol. 2017. PMID: 28924435 Free PMC article.
-
Role of fluorescein angiography guided laser treatment in aggressive retinopathy of prematurity.Eye (Lond). 2023 Jul;37(10):2130-2134. doi: 10.1038/s41433-022-02302-0. Epub 2022 Nov 3. Eye (Lond). 2023. PMID: 36329165 Free PMC article. Clinical Trial.
-
Ten-year outcomes after initial management with laser photocoagulation versus intravitreal bevacizumab injection in a pair of identical twins with aggressive posterior retinopathy of prematurity.Am J Ophthalmol Case Rep. 2021 May 2;22:101097. doi: 10.1016/j.ajoc.2021.101097. eCollection 2021 Jun. Am J Ophthalmol Case Rep. 2021. PMID: 34027226 Free PMC article.
-
The safety and effectiveness of 0.16 mg bevacizumab plus or minus additional laser photocoagulation in the treatment of retinopathy of prematurity.Indian J Ophthalmol. 2019 Jun;67(6):879-883. doi: 10.4103/ijo.IJO_2115_18. Indian J Ophthalmol. 2019. PMID: 31124508 Free PMC article.
References
-
- International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005;123:991–999. - PubMed
-
- Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121:1684–1694. - PubMed
-
- Morizane H. Initial sign and clinical course of the most severe form of acute proliferative retrolental fibroplasia (type II) Nihon Ganka Gakkai Zasshi. 1976;80:54–61. - PubMed
-
- Drenser KA, Trese MT, Capone A., Jr Aggressive posterior retinopathy of prematurity. Retina. 2010;30(4 Suppl):S37–S40. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources